ACI

ACI, founded in 1973, is a prominent Bangladeshi conglomerate with a diversified business portfolio. The company operates across three key reportable segments: Pharmaceuticals, Consumer Brands, and Agribusiness. Its extensive product offerings span from pharmaceuticals and vaccines to consumer goods and integrated agricultural solutions, reflecting its broad market engagement. ACI's commitment to quality is evident in its manufacturing processes and product development, aiming to serve diverse consumer and industrial needs.

With a substantial workforce exceeding 10,000 employees, ACI demonstrates significant operational scale. The company maintains a presence across 4 locations, extending its reach internationally with indications of operations in regions such as Asia, Europe, and North America. This global footprint supports its diverse business units, from pharmaceutical manufacturing to agribusiness. For insights into the leadership driving these operations, one can explore Meet ACI's team. The company's ticker symbol is DSE: ACI.

ACI's strategic diversification allows it to navigate various market dynamics, offering products ranging from Yamaha motorcycles and spare parts to essential medicines and agricultural inputs like feed additives and pond management solutions. The company's URL, www.aci-bd.com, provides further details on its extensive operations. As a publicly traded entity, ACI continues to evolve its offerings, leveraging its conglomerate structure to foster growth and innovation across its distinct business segments.